Jennifer Calls for an Eye Doctor (and You’ll Be Glad She Did!)

SPONSORED BY XDEMVY ®.

Please see Important Safety Information below.
There’s a lot of advice floating around online, but not all of it is true. That’s why “The Jennifer Hudson Show” invited beauty influencer Golloria to the Happy Place to bust some viral beauty and personal care myths!

When the topic of hygiene and eyelid mites comes up, Jennifer calls for an eye doctor -- and thank goodness Dr. Janelle Davison was in the audience! Dr. Davison explains that it's not about hygiene -- we all have eyelid mites. But some of us have an overpopulation of these mites, which can lead to a common eyelid disease called Demodex blepharitis, that can lead to symptoms such as eyelid redness, crusties, inflammation and more. This is why it’s so important to take care of your eyes and visit your eye doctor. #XDEMVYPartner

Rx only. Visit Xdemvy.com and ask your doctor if XDEMVY is right for you.

Dr. Janelle Davison is a paid spokesperson for Tarsus Pharmaceuticals.

Indications and Usage: XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis.

Important Safety Information

Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis.

Handling the Container: Avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

When to Seek Physician Advice: Immediately seek a physician’s advice concerning the continued use of XDEMVY if you develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions.

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals at 1-888-421-4002 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see full prescribing information at https://bit.ly/XDEMVY-PI.
Intended for U.S. audiences only.